Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection

Journal of Chromatography A

Volumn 1314, Issue , 2013, Pages 54-62

  Lomonaco, Tommaso ^a   Ghimenti, Silvia ^a   Piga, Isabella ^a   Onor, Massimo ^b   Melai, Bernardo ^a   Fuoco, Roger ^a   Di Francesco, Fabio ^a,c  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

High performance liquid chromatography; Sample preparation techniques; Warfarin; Warfarin alcohols

Indexed keywords

CHROMATOGRAPHIC SEPARATIONS; EXCITATION WAVELENGTH; FLUORESCENCE DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTIONS; RELATIVE STANDARD DEVIATIONS; REVERSED-PHASE COLUMNS; SAMPLE PREPARATION TECHNIQUES; WARFARIN;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; PATIENT TREATMENT; PLASMA (HUMAN);

CHROMATOGRAPHY;

ACETONITRILE; ANTICOAGULANT AGENT; HYDROXYWARFARIN; METHANOL; PHOSPHATE; UNCLASSIFIED DRUG; WARFARIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PRODUCT RECOVERY;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SAMPLE PREPARATION TECHNIQUES; WARFARIN; WARFARIN ALCOHOLS;

ALCOHOLS; ANTICOAGULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIQUID-LIQUID EXTRACTION; MAGNETIC RESONANCE SPECTROSCOPY; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; WARFARIN;

EID: 84884983387     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2013.08.091     Document Type: Article

References (37)

1. Pharmacy Times Top 200 Prescription Drugs of 2007 2007.
2. Ishihama Y., Oda Y., Asakaw N. Review report for the active substance warfarin 2005, http://ec.europa.eu/food/plant/protection/evaluation/existactive/warfarin_en.pdf.
3. Breckenridge A.M., Orme M., Wesseling H., Lewis R.J., Gibbons R. Clin. Pharmacol. Ther. 1974, 15:424.
4. Choonara I.A., Haynes B.P., Cholerton S., Breckenridge A.M., Park B.K. Br. J. Clin. Pharmacol. 1986, 22:729.
5. Epps D.E., Raub T.J., Kezdy F.J. Anal. Biochem. 1995, 227:342.
6. Stirling U., Howarth D.J., Stockley R., Bland R., Towler C.M., Harding S.M. Br. J. Haematol. 1982, 51:37.
7. Petitpas I., Bhattacharya A.A., Twine S., East M., Curry S. J. Biol. Chem. 2001, 22:276.
8. Routledge P.A., Chapman P.H., Davies D.M., Rawlins M.D. Br. J. Clin. Pharmacol. 1979, 8:243.
9. Ghimenti S., Lomonaco T., Onor M., Murgia L., Paolicchi A., Fuoco R., Ruocco L., Pellegrini G., Trivella M.G., Di Francesco F. PLoS ONE 2011, 12:1.
10. Lewis R.J., Trager W.F. J. Clin. Invest. 1970, 49:907.
11. Pohl R.L., Nelson S.D., Porter W.R., Trager W.F. Biochem. Pharmacol. 1976, 25(2153).
12. Chan K.K., Lewis R.J., Trager W.F. J. Med. Chem. 1972, 15:1265.
13. Lewis R.J., Trager W.F. J. Lab. Clin. Med. 1973, 81:925.
14. Chan E., McLachlan A.J., Rowland M. Eur. J. Pharm. Sci. 1994, 1:189.
15. Gebauer M. Bioorg. Med. Chem. 2007, 15:2414.
16. Wysowski D.K., Nourjah P., Swartz L. Arch. Intern. Med. 2007, 167:1414.
17. Holbrook A.M., Pereira J.A., Labiris R., McDonald H., Douketis J.D., Crowther M., Wells P.S. Arch. Intern. Med. 2005, 10:1095.
18. WHO Expert Committee on Biological Standardization Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. World Health Organ. Tech. Rep. Ser. 1999, 889:1.
19. Wang M., Cai Z., Xu L. J. Chromatogr. A 2011, 1218:4045.
20. Mahasen A.R., Bawazeer G.A., Aloudah N.M., Al Quadei B.T., Aboul-Enein H.Y. Biomed. Chromatogr. 2012, 26:6.
21. Know M.J., Kim H.J., Kim J.W., Lee K.H., Sohn K.H., Cho H.J., On Y.N., Kim J.S., Lee S.Y. Korean J. Lab. Med. 2009, 29:515.
22. Huang C., Yang J., Du Y., Miao L. Clin. Chim. Acta 2008, 393:85.
23. Jones D.R., Boysen G., Miller G.P. J. Chromatogr. B 2011, 879:1056.
24. Corn M., Berberich R. Clin. Chem. 1967, 13:126.
25. Trager W.F., Lewis R.J., Garland W.A. J. Med. Chem. 1970, 13:1196.
26. Naidong W., Lee J.W. J. Pharm. Biomed. Anal. 1993, 11:785.
27. Thompson M., Ellison S.L.R., Wood R. Pure Appl. Chem. 2002, 74:835.
28. Jensen B.P., Chin P.K.L., Begg E.J. Anal. Bioanal. Chem. 2011, 401:2187.
29. Currie L.A. Pure Appl. Chem. 1995, 67:1699.
30. Lee S.H., Field L.R., Howald W.N., Trager W.F. Anal. Chem. 1981, 53:467.
31. Hermans J.J., Thijssen H.H.W. Biochem. Pharmacol. 1989, 19:3365.
32. Lombardi R., Chantarangkul V., Cattaneo M., Tripodi A. Thromb. Res. 2003, 11:281.
33. Cai W.M., Hatton J., Pettigrew L.C., Dempsey R.J., Chandler M.H. Ther. Drug Monit. 1994, 16:509.
34. Locatelli I., Kmetec V., Mrhar A., Grabnar I. J. Chromatogr. B 2005, 818:191.
35. Sun S., Wang M., Su L., Li J., Li H., Gu D. J. Pharm. Biomed. Anal. 2006, 42:222.
36. Duffield A.M., Duffield P.H., Birkett D.J., Kennedy M., Wade D.N. Biomed. Mass Spectrom. 1979, 6:211.
37. Takahashi H., Kashima T., Nomizo Y., Muramoto N., Shimizu T., Nasu K., Kubota T., Kimura S., Echizen H. Clin. Pharmacol. Ther. 1998, 63:519.